Inventor
ROTH HOWARD S
US16 patents
⚠️ This page may combine multiple inventors who share the name “ROTH HOWARD S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHEMOCENTRYX INC
10 patentsUS11485708B2Nov 1, 2022
Compounds for treatment of PD-L1 diseases
CHEMOCENTRYX INC9 citations86
US11059834B2Jul 13, 2021
Macrocyclic immunomodulators
CHEMOCENTRYX INC10 citations85
US10919852B2Feb 16, 2021
Immunomodulator compounds
CHEMOCENTRYX INC15 citations85
US10392405B2Aug 27, 2019
Macrocyclic immunomodulators
CHEMOCENTRYX INC13 citations84
US11708326B2Jul 25, 2023
Immunomodulator compounds
CHEMOCENTRYX INC4 citations74
US11691985B2Jul 4, 2023
Macrocyclic immunomodulators
CHEMOCENTRYX INC4 citations74
US11427541B2Aug 30, 2022
Salt forms of a complement component C5A receptor
CHEMOCENTRYX INC2 citations72
US11872217B2Jan 16, 2024
Indanes as PD-L1 inhibitors
CHEMOCENTRYX INC0 citations52
US12018016B2Jun 25, 2024
Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors
CHEMOCENTRYX INC0 citations50
US12012403B2Jun 18, 2024
Aryl sulfonyl compounds as CCR6 inhibitors
CHEMOCENTRYX INC0 citations48
UNIV ILLINOIS
5 patentsUS9663482B2May 30, 2017
Substituted piperazinyl acetohydrazide procaspase-activating compounds
UNIV ILLINOIS8 citations83
US9249116B2Feb 2, 2016
Enzyme-activating compounds and compositions
UNIV ILLINOIS10 citations83
US10888560B2Jan 12, 2021
Procaspase 3 activation by combination therapy
UNIV ILLINOIS1 citations72
US11833147B2Dec 5, 2023
Procaspase 3 activation by combination therapy
UNIV ILLINOIS0 citations61
US10085977B2Oct 2, 2018
Procaspase 3 activation by combination therapy
UNIV ILLINOIS1 citations61